Latest Regulatory Delays News

Image Resources NL is broadening its project development focus beyond the newly commissioned Atlas mine, aiming to mitigate regulatory risks and ensure operational continuity through multiple potential mining projects.

BOA Resources advances drilling plans for key lithium and nickel tenements in Western Australia despite delays in heritage and environmental approvals, while actively reviewing its asset portfolio amid IGO's exit from Symons Hill.

Marvel Gold Limited is progressing its acquisition of the Hanang Gold Project in Tanzania with key regulatory approvals underway, while navigating delays in Mali that impact the sale of its Tabakorole and Yanfolila gold assets.

Titanium Sands Limited has secured retention licenses for four critical exploration areas and is progressing its Environmental Impact Assessment in Sri Lanka, while engaging government officials and local landowners to navigate regulatory hurdles.

DMC Mining’s planned acquisition of the Firawa and Labé uranium projects in Guinea faces delays due to exploration license approvals, while the company’s cash reserves dwindle to just A$14,000.

Bindi Metals reports steady progress on its Lisa antimony-gold project in Serbia alongside promising gallium mineralisation at its Australian Biloela copper-gold project, maintaining a solid cash position.

Perseus Mining delivered a strong June 2025 quarter, hitting production targets and maintaining a robust cash position of US$827 million, while progressing major projects including the Nyanzaga Gold Project in Tanzania.

Cooper Metals Limited reports steady progress across its copper-gold exploration portfolio in Queensland and Western Australia, underpinned by a solid cash position and advancing regulatory approvals.

Macarthur Minerals has extended the timetable for its A$2 million renounceable rights issue, providing shareholders additional time to participate amid ongoing regulatory scrutiny by ASIC. The company confirms no changes to the offer terms and expects to lodge an updated Supplementary Prospectus shortly.

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.

Macarthur Minerals has extended the timetable for its A$2 million renounceable rights issue, providing shareholders more time to participate amid ongoing regulatory scrutiny by ASIC.

Marvel Gold Limited has extended the completion date for the sale of its Mali gold projects to August 2025 due to ongoing regulatory delays, signaling cautious navigation of complex local approvals.